2008 ~ 2017
2017
Oncotarget
2017 Dec 13;9(1):1143-1155
Kim W, Pyo J, Noh BJ, Jeong JW, Lee J, Kim JE*.
CCAR2 negatively regulates IL-8 production in cervical cancer cells
2017
Br J Pharmacol
2017 Jun;174(12):1810-1825.
Choi M(co-first), Min YH(co-first), Pyo J, Lee CW, Jang CY, Kim JE*.
TC Mps1 12, a novel Mps1 inhibitor, suppresses a growth of hepatocellular carcinoma cells via accumulated chromosomal instability.
2017
Biochem Biophys Res Commun
2017 Apr 15;485(4):782-789.
Kim W, Cheon MG, Kim JE*.
Mitochondrial CCAR2/DBC1 is required for cell survival against rotenone-induced mitochondrial stress
2016
Oncotarget
2016 Dec 20; 7(51): 84718-84735.
Min YH, Kim W, Kim JE*.
The Aurora kinase A inhibitor TC-A2317 disrupts mitotic progression and inhibits cancer cell proliferation
2016
Oncotarget
2016 Jun 14; 7(30): 47253-47241.
Bae WY, Choi JS, Kim JE, Park C, Jeong JW.
Zingerone suppresses angiogenesis via inhibition of matrix metalloproteinases during tumor development
2016
Cancer Lett
2016 Apr 1;373(1):138-145.
Lee SD, Kim W, Jeong JW, Park JW, Kim JE*.
AK-1, a SIRT2 inhibitor, destabilizes HIF-1α and diminishes its transcriptional activity during hypoxia
2016
Oncotarget
2016 Mar 14; 7(17):23975-23987.
Shin DH, Choi YJ, Jin P, Yoon H, Chun YS, Shin HW, Kim JE, Park JW.
Distinct effects of SIRT1 in cancer and stromal cells on tumor promotion
2015
Biochem Pharmacol
2015 Nov 1; 98(1):41-50.
Bae WY, Choi JS, Kim JE, Jeong JW.
Cinnamic aldehyde suppresses hypoxia-induced angiogenesis via inhibition of hypoxia-inducible factor-1α expression during tumor progression
2015
Cancer Lett
2015 Feb 28;357(2):591-601.
Choi M, Kim W, Cheon MG, Lee CW, Kim JE*.
Polo-like kinase 1 inhibitor BI2536 causes mitotic catastrophe following activation of the spindle assembly checkpoint in non-small cell lung cancer cells
2015
Cancer Lett
2015 Jan 28;356(2 Pt B):637-645.
Cheon MG, Kim W, Choi M, Kim JE*.
AK-1, a specific SIRT2 inhibitor, induces cell cycle arrest by downregulating Snail in HCT116 human colon carcinoma cells
2014
Nucleic Acids Res
2014 Dec 1;42(21):13150-13160.
Magni M, Ruscica V, Buscemi G, Kim JE, Nachimuthu BT, Fontanella E, Delia D, Zannini L.
Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis
2014
Tumor Biol
2014 Nov; 35(11):10919-10929.
Kim W, Jeong JW, Kim JE*.
CCAR2 deficiency augments genotoxic stress-induced apoptosis in the presence of melatonin in non-small cell lung cancer cells
2014
Phytother Res
2014 Aug; 28(8):1246-1251.
Kong CS, Kim KH, Choi JS, Kim JE, Park C, Jeong JW.
Salicin, an Extract from White Willow Bark, Inhibits Angiogenesis by Blocking the ROS-ERK Pathways.
2014
Cell Cycle
2014 Mar; 13(5): 726-738.
Kim W, Choi M, Kim JE*.
The histone methyltransferase Dot1/DOT1L as a critical regulator of the cell cycle
[Review]
2013
J Physiol Pharmacol
2013 Oct; 64(5):531-534.
Kim W, Kim JE*.
SIRT7 an emerging sirtuin: Deciphering newer roles.
[Review]
2013
Cancer Lett
2013 Jun 10; 333(2):180-186.
Kim W, Kim JE*.
Deleted in breast cancer 1 (DBC1) deficiency results in apoptosis of breast cancer cells through impaired responses to UV-induced DNA damage.
2012
J Mol Cell Biol
2012 Oct; 4(5):294-303.
Zannini L, Buscemi G, Kim JE, Fontanelia E, Delia D.
DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.
2012
J Biol Chem
2012 Feb 17; 287(8):5588-5599.
Kim W, Kim R, Park G, Park JW*, Kim JE*.
The deficiency of H3K79 histone methyltransferase DOT1L inhibits cell proliferation
2011
FEBS Lett
2011 Jan 3; 585(1):219-224.
Park G, Jeong JW, Kim JE*.
SIRT1 deficiency attenuates MPP+-induced apoptosis in dopaminergic cells
2010
Mol Cell
2010 Jun 25; 38(6):864-878.
Lim JH, Lee YM, Chun YS, Chen J, Kim JE* (co-corresponding), Park JW*.
Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha
2010
Cancer Sci
2010 Jul; 101(7):1738-1744.
Sung JY, Kim R*(co-first), Kim JE* (co-corresponding), Lee J*.
The balance between SIRT1 and DBC1 expression is lost in breast cancer
2010
Protein J
2010 Apr; 29(3):213-223.
Park G, Gong Z, Chen J, Kim JE*.
Characterization of the DOT1L network: Implications of diverse roles for DOT1L
2010
Neoplasma
2010;57(4):365-368.
Kim JE*, Sung S.
Deleted in Breast Cancer 1 (DBC1) is a dynamically regulated protein
2010
Mol Cell
2010 Feb 12; 37(3):438-446.
Gong Z, Kim JE, Leung CC, Glover JN, Chen J.
BACH1/FANCJ acts with TopBP1 and participates early in DNA replication checkpoint control
2009
Cell Cycle
2009 Nov 15; 8(22):3784-3785.
Kim JE*, Lou Z, Chen J.
Interactions between DBC1 and SIRT1 are deregulated in breast cancer cells
2009
Cell Cycle
2009 Sep 15; 8(18):2932-2935.
Kim JE* (co-corresponding), Chen J, Lou Z*.
p30 DBC is a potential regulator of tumorigenesis
[Review]
2009
J Biol Chem
2009 Mar 13; 84(11):7284-7293.
Gong Z, Cho YW, Kim JE, Ge K, Chen J.
Accumulation of Pax2 transactivation domain interaction protein (PTIP) at sites of DNA breaks via RNF8-dependent pathway is required for cell survival after DNA damage
2008
Mol Cell Biol
2008 Apr; 28(8):2825-2839.
Steger DJ, Lefterova MI, Ying L, Stonestrom AJ, Schupp M, Zhou D, Vakoc AL, Kim JE, Chen J, Lazar MA, Blobel GA, Vakoc CR
DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells.
2008
Nature
2008 Jan 31; 451(7178):583-586.
Kim JE, Chen J, Lou Z.
DBC1 is a negative regulator of SIRT1